BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-3.96%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.5B
AUM Growth
+$11.5B
(-6.4%)
Cap. Flow
+$415M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
81.68%
Holding
129
New
8
Increased
22
Reduced
12
Closed
5
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$150M |
| 2 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$104M |
| 3 |
PHXM
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
|
$68M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$59.5M |
| 5 |
argenx
ARGX
|
$54.4M |
Top Sells
| 1 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$179M |
| 2 |
AKAO
Achaogen, Inc.
AKAO
|
$40.4M |
| 3 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$22.2M |
| 4 |
Exelixis
EXEL
|
$17.5M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$8.85M |
Sector Composition
| 1 | Healthcare | 93.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Exelixis
EXEL
$10B
| $45.8M | 0.4% |
1,506,499
-575,513
| -28% | -$17.5M |
|
|
BLCM
27
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $42.3M | 0.37% |
5,032,313
| – | – |
|
|
ACGN
28
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $38.6M | 0.34% |
18,315,802
+8,009,045
| +78% | +$16.9M |
|
|
RXDX
29
DELISTED
Ignyta, Inc.
RXDX
| $37M | 0.32% |
1,384,266
+85,067
| +7% | +$2.27M |
|
|
BLUE
30
DELISTED
bluebird bio
BLUE
| $35.6M | 0.31% |
200,000
-41,441
| -17% | -$7.38M |
|
31
Sangamo Therapeutics
SGMO
$165M
| $34.7M | 0.3% |
2,113,376
| – | – |
|
32
Cerus
CERS
$249M
| $32.9M | 0.29% |
9,745,209
| – | – |
|
33
Halozyme
HALO
$8.76B
| $32M | 0.28% |
1,581,424
| – | – |
|
34
Abeona Therapeutics
ABEO
$357M
| $31.5M | 0.27% |
1,984,364
+300,000
| +18% | +$4.75M |
|
|
GWPH
35
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $29.3M | 0.25% |
221,800
+146,800
| +196% | +$19.4M |
|
|
CBAY
36
DELISTED
Cymabay Therapeutics
CBAY
| $27.5M | 0.24% |
2,991,775
| – | – |
|
|
AIMT
37
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $25.5M | 0.22% |
673,908
| – | – |
|
38
Galapagos
GLPG
$2.05B
| $24.4M | 0.21% |
259,894
| – | – |
|
39
Catalyst Pharmaceutical
CPRX
$2.51B
| $22.9M | 0.2% |
5,852,153
+750,000
| +15% | +$2.93M |
|
40
Merus
MRUS
$5.06B
| $22.5M | 0.2% |
1,160,014
| – | – |
|
41
Intellia Therapeutics
NTLA
$1.26B
| $22M | 0.19% |
1,145,453
+83,333
| +8% | +$1.6M |
|
42
Insmed
INSM
$30.6B
| $21.8M | 0.19% |
700,000
| – | – |
|
43
Xencor
XNCR
$586M
| $19.1M | 0.17% |
872,072
| – | – |
|
|
PGNX
44
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $18.7M | 0.16% |
3,150,808
| – | – |
|
45
AnaptysBio
ANAB
$594M
| $18.3M | 0.16% |
181,386
+70,000
| +63% | +$7.05M |
|
|
AERI
46
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $17.9M | 0.16% |
299,356
| – | – |
|
|
IMGN
47
DELISTED
Immunogen Inc
IMGN
| $16.4M | 0.14% |
2,563,489
-125,000
| -5% | -$801K |
|
|
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $15M | 0.13% |
355,264
| – | – |
|
|
FOMX
49
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $14.8M | 0.13% |
2,466,702
| – | – |
|
50
Assembly Biosciences
ASMB
$184M
| $14.6M | 0.13% |
322,727
+72,727
| +29% | +$3.29M |
|